Erythroplasia of Queyrat treated with imiquimod 5% cream

Journal of the American Academy of Dermatology

Volumn 55, Issue 5, 2006, Pages 901-903

  Micali, Giuseppe ^a   Nasca, Maria Rita ^a   De Pasquale, Rocco ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; IMIQUIMOD; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ANTINEOPLASTIC ACTIVITY; APPLICATION SITE BURNING; ARTICLE; CARCINOMA IN SITU; CASE REPORT; CONCENTRATION RESPONSE; CREAM; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG ERUPTION; DRUG MECHANISM; ERYTHROPLASIA; ERYTHROPLASIA OF QUEYRAT; HUMAN; HUMAN TISSUE; MALE; PAPILLOMA VIRUS; PENIS CARCINOMA; PENIS GLANS; PRIORITY JOURNAL; VIRUS DETECTION;

ADJUVANTS, IMMUNOLOGIC; AMINOQUINOLINES; CARCINOMA IN SITU; DRUG ADMINISTRATION SCHEDULE; ERYTHROPLASIA; HUMANS; MALE; MIDDLE AGED; OINTMENTS; PENILE NEOPLASMS; TREATMENT OUTCOME;

EID: 33749674317     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2006.07.021     Document Type: Article

References (12)

1. Perry C.M., and Lamb H.M. Topical imiquimod: a review of its use in genital warts. Drugs 58 (1999) 375-390
2. Syed T.A., Goswami J., Ahmadpour O.A., and Ahmad S.A. Treatment of molluscum contagiosum in males with an analog of imiquimod 1% in cream: a placebo-controlled, double-blind study. J Dermatol 25 (1998) 309-313
3. Christensen B., and Hengge U.R. Recurrent urogenital herpes simplex - successful treatment with imiquimod?. Sex Transm Infect 75 (1999) 132-133
4. Smith K.J., Germain M., and Skelton H. Bowen's disease (squamous cell carcinoma in situ) in immunosuppressed patients treated with imiquimod 5% cream and a COX inhibitor, Sulindac: potential applications for this combination of immunotherapy. Dermatol Surg 27 (2001) 143-146
5. McKenzie-Wood A., Kossard S., De Launey J., Wilkinson B., and Owens M.L. Imiquimod 5% cream in the treatment of Bowen's disease. J Am Acad Dermatol 44 (2001) 462-470
6. Ahmed I., and Berth-Jones J. Imiquimod: a novel treatment for lentigo maligna. Br J Dermatol 143 (2000) 843-845
7. Hannuksela-Svahn A., Nordal E., and Christensen O.B. Treatment of multiple basal cell carcinomas in the scalp with imiquimod 5% cream. Acta Derm Venereol 80 (2000) 381-382
8. Marks R., Gebauer K., Shumack S., Amies M., Bryden J., Fox T.L., et al. Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial. J Am Acad Dermatol 44 (2001) 807-813
9. Testerman T.L., Gerster J.F., Imbertson L.M., Reiter M.J., Miller R.L., Gibson S.J., et al. Cytokine induction by immunomodulators imiquimod and S-27609. J Leukoc Biol 58 (1995) 365-372
10. Wieland U., Jurk S., Weissenborn S., Krieg T., Pfister H., and Ritzkowsky A. Erythroplasia of Queyrat: coinfection with cutaneous carcinogenic human papillomavirus type 8 and genital papillomaviruses in a carcinoma in situ. J Invest Dermatol 115 (2000) 396-401
11. Micali G., Nasca M.R., and Musumeci M.L. Cryotherapy for Bowen's disease of the male genitalia. J Am Acad Dermatol 38 (1998) 504-505
12. Hengge U.R., and Stark R. Topical imiquimod to treat intraepidermal carcinoma. Arch Dermatol 137 (2001) 709-711